Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,642
datasets available to search
ShareScore release 0.9.0
Dataset results
2,642 results for “blindness”
Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate
ClinicalTrials.gov study NCT02232087. IPD Sharing: NO. Countries: 1. Publications: 1.
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
ClinicalTrials.gov study NCT00475085. IPD Sharing: Not stated. Countries: 1. Publications: 1.
B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults
ClinicalTrials.gov study NCT03532425. IPD Sharing: NO. Countries: 1. Publications: 2.
Blinded Dry Mouth Spray Crossover Study
ClinicalTrials.gov study NCT04608773. IPD Sharing: NO. Countries: 1. Publications: 3.
A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)
ClinicalTrials.gov study NCT02497001. IPD Sharing: YES. Countries: 4. Publications: 12.
A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01539512. IPD Sharing: YES. Countries: 5. Publications: 3.
A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149
ClinicalTrials.gov study NCT01709903. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis
ClinicalTrials.gov study NCT00809159. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrroniu
ClinicalTrials.gov study NCT01712516. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Pers
ClinicalTrials.gov study NCT01152450. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of
ClinicalTrials.gov study NCT00160706. IPD Sharing: Not stated. Countries: 24. Publications: 1.
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral
ClinicalTrials.gov study NCT01953081. IPD Sharing: NO. Countries: 1. Publications: 1.
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
ClinicalTrials.gov study NCT00880048. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
ClinicalTrials.gov study NCT00506441. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
ClinicalTrials.gov study NCT01810939. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
ClinicalTrials.gov study NCT05172050. IPD Sharing: NO. Countries: 3. Publications: 1.
Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal In
ClinicalTrials.gov study NCT00701714. IPD Sharing: Not stated. Countries: 10. Publications: 1.
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
ClinicalTrials.gov study NCT01084174. IPD Sharing: NO. Countries: 1. Publications: 1.
Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)
ClinicalTrials.gov study NCT04928287. IPD Sharing: NO. Countries: 1. Publications: 0.
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
ClinicalTrials.gov study NCT06179108. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.